DiSilvestro P

No ORCID on file · 5 papers in corpus
rct 2019
The New England journal of medicine ·doi:10.1056/nejmoa1902626

BACKGROUND: Secondary surgical cytoreduction in women with platinum-sensitive, recurrent epithelial ovarian, primary peritoneal, or fallopian-tube ("ovarian") cancer is widely practiced but has not been evaluated in phase 3 investigation. …

other 2015
Gynecologic Oncology ·doi:10.1016/j.ygyno.2015.09.010

OBJECTIVE: To evaluate the use of as an aid in the identification of women who can safely undergo conservative, non-surgical management. METHODS: All patients referred to the Program in Women's Oncology for surgery with a pelvic mass are e…

nonrandomized-trial 2014
Journal of Clinical Oncology ·doi:10.1200/jco.2013.54.1987

PURPOSE: Risk-reducing salpingo-oophorectomy (RRSO) lowers mortality from ovarian/tubal and breast cancers among BRCA1/2 mutation carriers. Uncertainties persist regarding potential benefits of RRSO among high-risk noncarriers, optimal surg…

nonrandomized-trial 2011
Obstetrics and gynecology ·doi:10.1097/aog.0b013e318224fce2

OBJECTIVE: It is often difficult to distinguish a benign pelvic mass from a malignancy and tools to help referring physician are needed. The purpose of this study was to validate the Risk of Ovarian Malignancy Algorithm in women presenting …

nonrandomized-trial 2009
Gynecologic Oncology ·doi:10.1016/j.ygyno.2008.08.031

INTRODUCTION: Patients diagnosed with epithelial ovarian cancer (EOC) have improved outcomes when cared for at centers experienced in the management of EOC. The objective of this trial was to validate a predictive model to assess the risk f…